SINOPHARM GROUP 1/5/O.N. Net Asset Momentum
SINOPHARM GROUP 1/5/O.N. net asset momentum. SINOPHARM GROUP 1/5/O.N. (X2S1) recorded a net asset momentum of 5.9% as of December 2025, with net assets of €134.16 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore X2S1 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of SINOPHARM GROUP 1/5/O.N. (2021–2025)
Net asset momentum of SINOPHARM GROUP 1/5/O.N. from 2021 to 2025. This chart tracks SINOPHARM GROUP 1/5/O.N.'s year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +5.9%, with net assets of €134.16 Billion EUR as of December 2025. See SINOPHARM GROUP 1/5/O.N. shareholders equity for net asset value and shareholders' equity analysis.
SINOPHARM GROUP 1/5/O.N. Net Asset Momentum by Year (2021–2025)
SINOPHARM GROUP 1/5/O.N. net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for SINOPHARM GROUP 1/5/O.N. from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see SINOPHARM GROUP 1/5/O.N. market cap and net worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €134.16 Billion | €390.36 Billion | €256.20 Billion | ▲ +5.9% |
| 2024 | €126.69 Billion | €392.83 Billion | €266.14 Billion | ▲ +5.3% |
| 2023 | €120.32 Billion | €383.39 Billion | €263.08 Billion | ▲ +9.3% |
| 2022 | €110.07 Billion | €364.78 Billion | €254.71 Billion | ▲ +10.5% |
| 2021 | €99.65 Billion | €335.41 Billion | €235.76 Billion | — |